Month: May 2016

Fort Lauderdale Biotech Company Launches Oral Cancer Test May 31, 2016 Vigilant Biosciences is making its oral rinse test available to dentists in the United States, the Fort Lauderdale startup company said Tuesday. The laboratory test is designed to measure a biomarker for oral cancer detection at its earliest stages. The OncAlert Labs OraMark Test

Vigilant Creates New Clinical Officer Position May 25, 2016 Vigilant Biosciences has appointed Michael Donovan, MD, PhD, as the its new chief clinical officer. Dr. Donovan will be part of the executive management team and is responsible for advancing Vigilant’s oral cancer product line. He received his medical degree from the University of Medicine and

Vigilant Biosciences Receives CE Mark for OncAlert Oral Cancer Rapid Test May 13, 2016 The CE mark, a mandatory conformity marking in the European Union (EU), will allow the product to be sold in the 28 countries of the EU and Norway, Iceland, Liechtenstein and Switzerland. Vigilant Biosciences Inc. has announced that it has CE

Vigilant Biosciences Cleared to Launch its Oral Cancer Test Across Europe May 4, 2016 Vigilant Biosciences, an early-stage Fort Lauderdale-based company that develops solutions that aid in the early detection and intervention of cancer, announced that it has CE Marked its OncAlert Oral Cancer RAPID Test, meaning it can market the product in the 28

Fort Lauderdale Company’s CancerTest Receives European Marketing Approval May 4, 2016 Vigilant Biosciences, a startup company in Fort Lauderdale, has received European Commission approval to market its oral cancer testing product. European approval to sell the product “is a major milestone for our company as it enables us to initiate manufacturing and sales efforts across